October 2026
Proxalutamide COVID-19 outcomes
StudyImprovementRR · 95% CIOutcomeTreatmentControlRelative Risk
McCoy (DB RCT)80%0.20 · 0.01–4.13death0/1342/134censored, see details CS1
McCoy (DB RCT)97%0.03 · 0.00–0.47ventilation0/13417/134censored, see details CS1
McCoy (DB RCT)91%0.09 · 0.03–0.27hosp.3/13435/134censored, see details CS1
Cadegiani (DB RCT)63%0.37 · 0.02–8.85death0/751/102
Cadegiani (DB RCT)90%0.10 · 0.01–1.84ventilation0/755/102
Cadegiani (DB RCT)86%0.14 · 0.03–0.60hosp.2/7519/102
Kintor (DB RCT)67%0.33 · 0.01–8.16death0/3651/365
Kintor (DB RCT)50%0.50 · 0.15–1.65hosp.4/3658/365
Kintor (DB RCT)67%0.33 · 0.01–8.16death0/3601/361
Kintor (DB RCT)71%0.29 · 0.06–1.37hosp.2/3607/361
Kintor (DB RCT)67%0.33 · 0.01–8.16death0/3461/347
Kintor (DB RCT)92%0.08 · 0.00–1.36hosp.0/3466/347
Kintor (DB RCT)74%0.26 · 0.13–0.51viral+365 (n)365 (n)
Cadegiani (DB RCT)78%0.22 · 0.16–0.30death45/423171/355
Cadegiani (DB RCT)79%0.21 · 0.15–0.30death34/423138/355
Cadegiani (DB RCT)45%0.55 · 0.49–0.62no recov.423 (n)355 (n)
Cadegiani (DB RCT)55%0.45 · 0.39–0.52no recov.423 (n)355 (n)
Cadegiani (DB RCT)33%0.67 · 0.54–0.82hosp. time423 (n)355 (n)
00.511.52+